Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19

NCT04391179 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT04391179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04391179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19
Lead sponsor
University of Michigan
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2020
Completion date
February 22, 2021
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid, covid-19, sars-cov-2 infection